Infinity Pharmaceuticals, Inc. Construction and Development Costs (Deprecated 2018-01-31)
Infinity Pharmaceuticals, Inc. reported Construction and Development Costs (Deprecated 2018-01-31) of $22.80 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ConstructionAndDevelopmentCosts · last filed 2016-05-04
- Infinity Pharmaceuticals, Inc. construction and development costs (deprecated 2018-01-31) for the quarter ending 2016-03-31 was $22.80M, a 15.74% increase year-over-year.
- Infinity Pharmaceuticals, Inc. construction and development costs (deprecated 2018-01-31) for the quarter ending 2015-12-31 was -$200.00K.
- Infinity Pharmaceuticals, Inc. construction and development costs (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $200.00K.
- Infinity Pharmaceuticals, Inc. construction and development costs (deprecated 2018-01-31) for the quarter ending 2015-06-30 was $3.30M.
- Infinity Pharmaceuticals, Inc. construction and development costs (deprecated 2018-01-31) for fiscal 2014 was $16.00M.
| Period end | Construction and Development Costs (Deprecated 2018-01-31) 3 month | Construction and Development Costs (Deprecated 2018-01-31) 6 month | Construction and Development Costs (Deprecated 2018-01-31) 9 month | Construction and Development Costs (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2016-03-31 | $22.80M 10-Q · filed 2016-05-04 | $22.60M derived: sum of 2 quarters · filed 2016-05-04 | $22.80M derived: sum of 3 quarters · filed 2016-05-04 | $26.10M derived: sum of 4 quarters · filed 2016-05-04 |
| 2015-12-31 | -$200.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2016-05-04 | $0.00 derived: sum of 2 quarters · filed 2016-05-04 | $3.30M derived: sum of 3 quarters · filed 2016-05-04 | $23.00M 10-Q · filed 2016-05-04 |
| 2015-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $3.50M derived: sum of 2 quarters · filed 2015-11-05 | $23.20M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $23.00M 10-Q · filed 2015-08-06 | ||
| 2015-03-31 | $19.70M 10-Q · filed 2015-05-06 | |||
| 2014-12-31 | $16.00M 10-K · filed 2016-02-23 |